Cliff Asness's MDGL Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 6,586 shares of Madrigal Pharmaceuticals, Inc. (MDGL) worth $3.02 M, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in MDGL, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2018, adding 6,052 shares. Largest reduction occurred in Q3 2018, reducing 4,749 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Madrigal Pharmaceuticals (MDGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Madrigal Pharmaceuticals (MDGL) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2018 | +5,738 | New Buy | 5,738 | $116.77 |
| Q2 2018 | +6,052 | Add 105.47% | 11,790 | $279.73 |
| Q3 2018 | -4,749 | Reduce 40.28% | 7,041 | $214.17 |
| Q4 2018 | -2,086 | Reduce 29.63% | 4,955 | $112.82 |
| Q1 2019 | -4,955 | Sold Out | 4,955 | $0.00 |
| Q4 2022 | +1,885 | New Buy | 1,885 | $290.25 |
| Q1 2023 | +4,796 | Add 254.43% | 6,681 | $242.26 |
| Q2 2023 | -154 | Reduce 2.31% | 6,527 | $231.00 |
| Q3 2023 | -301 | Reduce 4.61% | 6,226 | $146.04 |
| Q4 2023 | -113 | Reduce 1.81% | 6,113 | $231.38 |
| Q1 2024 | -808 | Reduce 13.22% | 5,305 | $267.04 |
| Q2 2024 | -695 | Reduce 13.10% | 4,610 | $280.16 |
| Q3 2024 | +508 | Add 11.02% | 5,118 | $212.22 |
| Q4 2024 | +364 | Add 7.11% | 5,482 | $308.57 |
| Q1 2025 | -1,710 | Reduce 31.19% | 3,772 | $331.23 |
| Q2 2025 | -605 | Reduce 16.04% | 3,167 | $302.64 |
| Q3 2025 | +3,419 | Add 107.96% | 6,586 | $458.66 |
Cliff Asness's Madrigal Pharmaceuticals Investment FAQs
Cliff Asness first purchased Madrigal Pharmaceuticals, Inc. (MDGL) in Q1 2018, acquiring 5,738 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Madrigal Pharmaceuticals, Inc. (MDGL) for 31 quarters since Q1 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to Madrigal Pharmaceuticals, Inc. (MDGL) was in Q2 2018, adding 11,790 shares worth $3.3 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 6,586 shares of Madrigal Pharmaceuticals, Inc. (MDGL), valued at approximately $3.02 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Madrigal Pharmaceuticals, Inc. (MDGL) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in Madrigal Pharmaceuticals, Inc. (MDGL) was 11,790 shares, as reported at the end of Q2 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.